-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Regeneron Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from 2010 to 2023.
- Regeneron Pharmaceuticals, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $2.54B, a 12.9% increase year-over-year.
- Regeneron Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $9.87B, a 11.2% increase year-over-year.
- Regeneron Pharmaceuticals, Inc. annual Costs and Expenses for 2023 was $9.07B, a 22% increase from 2022.
- Regeneron Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $7.43B, a 4.34% increase from 2021.
- Regeneron Pharmaceuticals, Inc. annual Costs and Expenses for 2021 was $7.12B, a 44.8% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)